Search Results - "Forner, Alejandro"

Advancing radiology reporting with large language models: Is GPT- 4 the LI- RADS game changer or just a wild card?

Authors: Díaz González, Álvaro Forner, Alejandro Turnes, Juan

Source: Liver International. Jul2024, Vol. 44 Issue 7, p1575-1577. 3p.

Barcelona Clinic Liver Cancer 2022 update: Linking prognosis prediction and evidence‐based treatment recommendation with multidisciplinary clinical decision‐making.

Authors: Mauro, Ezequiel Forner, Alejandro

Source: Liver International. Mar2022, Vol. 42 Issue 3, p488-491. 4p. 1 Diagram.

Immunotherapy in biliary tract cancer: The race has begun!

Authors: Mauro, Ezequiel Forner, Alejandro

Source: Liver International. Aug2023, Vol. 43 Issue 8, p1620-1622. 3p. 1 Chart.

The complexity of cholangiocarcinoma goes beyond clinical practice: Challenges in trials design and interpretation.

Authors: Da Fonseca, Leonardo G. Forner, Alejandro

Source: Liver International. Feb2022, Vol. 42 Issue 2, p268-270. 3p. 1 Chart.

Hepatocellular adenoma in men: Is it time for a precision approach?

Authors: Mauro, Ezequiel Forner, Alejandro

Source: Liver International. Oct2021, Vol. 41 Issue 10, p2246-2248. 3p. 1 Diagram.

Performance of gadoxetic acid MRI and diffusion-weighted imaging for the diagnosis of early recurrence of hepatocellular carcinoma.

Authors: Rimola, Jordi Forner, Alejandro Sapena, Víctor et al.

Source: European Radiology. Jan2020, Vol. 30 Issue 1, p186-194. 9p. 3 Diagrams, 4 Charts.

Subjects: Diffusion magnetic resonance imaging, Early diagnosis, Hepatitis C virus, Salvage therapy, Informed consent (Medical law)

Prospective evaluation of gadoxetic acid magnetic resonance for the diagnosis of hepatocellular carcinoma in newly detected nodules ≤2 cm in cirrhosis.

Authors: Ayuso, Carmen Forner, Alejandro Darnell, Anna et al.

Source: Liver International. Jul2019, Vol. 39 Issue 7, p1281-1291. 11p. 4 Diagrams, 4 Charts.

Clinical presentation, diagnosis and staging of cholangiocarcinoma.

Authors: Forner, Alejandro Vidili, Gianpaolo Rengo, Marco et al.

Source: Liver International. May2019 Supplement S1, Vol. 39, p98-107. 10p. 2 Color Photographs, 2 Black and White Photographs, 1 Chart.

Hepatobiliary contrast agents in MR: Where we stand and future perspectives.

Authors: Rimola, Jordi Forner, Alejandro

Source: Liver International. May2021, Vol. 41 Issue 5, p888-890. 3p. 1 Chart.

The tireless search to improve the prognostic assessment of intrahepatic cholangiocarcinoma: An urgent need.

Authors: Muñoz‐Martínez, Sergio Forner, Alejandro

Source: Liver International. Feb2021, Vol. 41 Issue 2, p252-254. 3p. 1 Chart.

Increasing alternatives in systemic treatment for hepatocellular carcinoma: Will algorithms be understandable?

Authors: Da Fonseca, Leonardo G. Forner, Alejandro

Source: Liver International. Aug2020, Vol. 40 Issue 8, p1829-1831. 3p. 1 Diagram.

Adherence and quality are key for a beneficial HCC surveillance.

Authors: Da Fonseca, Leonardo G. Forner, Alejandro

Source: Liver International. Apr2020, Vol. 40 Issue 4, p751-753. 3p. 1 Diagram.

Diagnostic performance of contrast-enhanced US in small liver nodules not conclusively characterized after MRI in cirrhotic patients.

Authors: Saborido, Belén Darnell, Anna Forner, Alejandro et al.

Source: European Radiology. Sep2025, Vol. 35 Issue 9, p5771-5780. 10p.

Subjects: Contrast-enhanced ultrasound, Hepatocellular carcinoma, Liver tumors, Diagnostic examinations, Noninvasive diagnostic tests, Cirrhosis of the liver, Magnetic resonance imaging

Should Artificial Intelligence‐based language models be allowed in developing scientific manuscripts? A debate between ChatGPT and the editors of Liver International.

Authors: Aghemo, Alessio Forner, Alejandro Valenti, Luca

Source: Liver International. May2023, Vol. 43 Issue 5, p956-957. 2p.

BCLC strategy for prognosis prediction and treatment recommendation: The 2022 update.

Authors: Reig, Maria Forner, Alejandro Rimola, Jordi et al.

Source: Journal of Hepatology. Mar2022, Vol. 76 Issue 3, p681-693. 13p.

A phase II open label trial evaluating safety andefficacy of a telomerase peptide vaccination inpatients with advanced hepatocellular carcinoma.

Authors: Greten, Tim F. Forner, Alejandro Korangy, Firouzeh et al.

Source: BMC Cancer. 2010, Vol. 10, p209-215. 7p.

New drugs for the treatment of hepatocellular carcinoma.

Authors: Boucher, Eveline Forner, Alejandro Reig, Maria et al.

Source: Liver International. Jan2009 Supplement, Vol. 29, p148-158. 11p. 1 Diagram, 3 Charts, 2 Graphs.

Editorial: aspirin and NSAID for chemoprevention of hepatocellular carcinoma—ready for their use?

Authors: Da Fonseca, Leonardo Gomes Forner, Alejandro

Source: Alimentary Pharmacology & Therapeutics. Sep2021, Vol. 54 Issue 6, p850-851. 2p.

Transarterial chemoembolization for patients with hepatocellular carcinoma.

Authors: Forner, Alejandro Real, M Isabel Varela, Maria et al.

Source: Hepatology Research. Sep2007 Supplement 2, Vol. 37, pS230-S237. 8p. 1 Black and White Photograph, 1 Diagram, 1 Chart.

Evidence and choice: The BCLC vision for tailoring clinical decision-making.

Authors: Reig, Maria Forner, Alejandro Rimola, Jordi et al.

Source: Journal of Hepatology. Oct2024, Vol. 81 Issue 4, pe176-e177. 2p.